John F. Chin
Director/Board Member at ANTENGENE CORPORATION LIMITED
Net worth: 226 343 $ as of 2024-05-30
John F. Chin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 2020-08-17 | - |
| Corporate Officer/Principal | 2020-08-17 | - | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 1998-09-30 | - |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Career history of John F. Chin
Former positions of John F. Chin
| Companies | Position | Start | End |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 2004-12-31 | 2019-12-31 |
Training of John F. Chin
| University of Arizona | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Statistics
International
| United States | 5 |
| China | 3 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- John F. Chin
- Experience
